Starting December 2018 we moved to Twitter and Facebook for our most recent updates!!!

91% response rate to the combination of venetoclax with azacitidine in older adults newly diagnosed with acute myeloid leukemia (AML)" Clinical trial results published in the journal Nature Medicine show 91 percent response rate to the combination of venetoclax with azacitidine in older adults newly diagnosed with acute myeloid leukemia (AML). Of 33 patients given combination venetoclax and azacitidine, 20 experienced a complete response (aka complete remission) and eight exp